Produces medical cannabis for patients and recreational users.
Jun 2026Revenue $1.70M/yrExpenses $4.59M/yr
No trendCash runway ≈ 1 months from Mar 2026
Figures by year
When will Cannapharmarx be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.70M and expenses $4.59M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.36M | $4.71M | −$3.35M |
| Dec 2024 | $820K | $4.45M | −$3.63M |
| Dec 2023 | $0.00 | $1.58M | −$1.58M |
| Dec 2022 | $0.00 | $5.21M | −$5.21M |
| Dec 2021 | $0.00 | $2.99M | −$2.99M |
| Dec 2020 | $0.00 | $14.5M | −$14.5M |
| Dec 2019 | $0.00 | $16.0M | −$16.0M |
| Dec 2018 | $0.00 | $954K | −$954K |
| Dec 2017 | $0.00 | $6.63K | −$6.63K |
| Dec 2016 | $0.00 | $1.00M | −$1.00M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.